Cargando…

Correction: A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271667/ https://www.ncbi.nlm.nih.gov/pubmed/32414863 http://dx.doi.org/10.1136/jitc-2020-0796-5corr1

Ejemplares similares

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
por: Rammensee, Hans-Georg, et al.
Publicado: (2019)

Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
por: van den Ende, Thomas C., et al.
Publicado: (2020)

Correction: The Toll-like receptor ligand, CpG oligodeoxynucleotides, regulate proliferation and osteogenic differentiation of osteoblast
por: Yu, Wenwen, et al.
Publicado: (2023)

Correction: Multimerization strategies for efficient production and purification of highly active synthetic cytokine receptor ligands
por: Mossner, Sofie, et al.
Publicado: (2020)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor Ligands
por: Toussi, Deana N., et al.
Publicado: (2014)

Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
por: Gableh, Fateme, et al.
Publicado: (2016)

The effects of in ovo administration of encapsulated Toll-like receptor 21 ligand as an adjuvant with Marek’s disease vaccine
por: Bavananthasivam, Jegarubee, et al.
Publicado: (2018)

Development of COVID-19 vaccine using a dual Toll-like receptor ligand liposome adjuvant
por: Abhyankar, Mayuresh M., et al.
Publicado: (2021)

Correction: Computational Study of Synthetic Agonist Ligands of Ionotropic Glutamate Receptors
por: Wolter, Tino, et al.
Publicado: (2014)

Correction: Identification of Potential Pathway Mediation Targets in Toll-like Receptor Signaling
por: Li, Fan, et al.
Publicado: (2009)

Correction: Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
por: Sun, Hao, et al.
Publicado: (2022)

Toll-Like Receptors, Their Ligands, and Atherosclerosis
por: Hodgkinson, Conrad P., et al.
Publicado: (2011)

Immunomodulatory Response of Toll-like Receptor Ligand–Peptide Conjugates in Food Allergy
por: Losada Méndez, Jorge, et al.
Publicado: (2021)

A new “sweet” ligand for Toll-like receptor 4
por: Deierborg, Tomas, et al.
Publicado: (2015)

Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant
por: Andersen, Brian M., et al.
Publicado: (2016)

Correction: Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria
Publicado: (2020)

Correction: Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo
Publicado: (2015)

Correction: mRNA-Mediated Gene Supplementation of Toll-Like Receptors as Treatment Strategy for Asthma In Vivo
por: Zeyer, Franziska, et al.
Publicado: (2018)

Correction: Development of a novel immunoproteasome digestion assay for synthetic long peptide vaccine design
por: Wada, Hiroshi, et al.
Publicado: (2018)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Correction: Serrano, R.; Wesch, D.; Kabelitz, D. Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes. Cells 2020, 9, 713
por: Serrano, Ruben, et al.
Publicado: (2020)

Correction: Retinal Muller Glia Initiate Innate Response to Infectious Stimuli via Toll-Like Receptor Signaling
por: Kumar, Ashok, et al.
Publicado: (2012)

Correction: Toll-Like Receptor (TLR) 2 and TLR4 Differentially Regulate Doxorubicin Induced Cardiomyopathy in Mice
por: Ma, Yonggang, et al.
Publicado: (2012)

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
por: Matissek, Stephan J., et al.
Publicado: (2023)

Bacterial Protein Toll-Like-Receptor Agonists: A Novel Perspective on Vaccine Adjuvants
por: Kumar, Sudeep, et al.
Publicado: (2019)

Correction: Toll-Like Receptor 4 Mutant and Null Mice Retain Morphine-Induced Tolerance, Hyperalgesia, and Physical Dependence
Publicado: (2014)

Correction: Toll-Like Receptor Signaling in Vertebrates: Testing the Integration of Protein, Complex, and Pathway Data in the Protein Ontology Framework
por: Arighi, Cecilia, et al.
Publicado: (2015)

Correction: Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-Like Receptor Pathway Deregulation in Colorectal Cancer
por: Xu, Ye, et al.
Publicado: (2013)

Correction to: Fetal Membrane Inflammation Induces Preterm Birth Via Toll-Like Receptor 2 in Mice With Chronic Gingivitis
por: Konishi, Haruhisa, et al.
Publicado: (2021)

Endogenous toll-like receptor ligands and their biological significance
por: Yu, Li, et al.
Publicado: (2010)

Role of Toll-like Receptors in Adjuvant-Augmented Immune Therapies
por: Seya, Tsukasa, et al.
Publicado: (2006)

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
por: Yang, Jing-Xing, et al.
Publicado: (2022)

Correction: Heme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 Dependent
por: Dickinson-Copeland, Carmen M., et al.
Publicado: (2016)

Correction: Pathophysiology of Endometriosis: Role of High Mobility Group Box-1 and Toll-Like Receptor 4 Developing Inflammation in Endometrium
por: Yun, Bo Hyon, et al.
Publicado: (2018)

Correction: Soluble Toll-Like Receptors 2 and 4 in Cerebrospinal Fluid of Patients with Acute Hydrocephalus following Aneurysmal Subarachnoid Haemorrhage
por: Sokół, Bartosz, et al.
Publicado: (2016)

Multivalent, Stabilized Mannose‐6‐Phosphates for the Targeted Delivery of Toll‐Like Receptor Ligands and Peptide Antigens
por: Reintjens, Niels R. M., et al.
Publicado: (2020)

Correction to: Toll-like receptor-mediated innate immunity against herpesviridae infection: a current perspective on viral infection signaling pathways
por: Zheng, Wenjin, et al.
Publicado: (2020)

Correction: Toll-like receptor 9 deficiency induces osteoclastic bone loss via gut microbiota-associated systemic chronic inflammation
por: Ding, Peng, et al.
Publicado: (2022)

Toll-like receptor ligands regulate the migratory pattern of leukocytes
por: Nieto, J C, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9aeaeejc9v3o3bifa57qv86l4n